Media

MGH-HKU-Nature China Forum To explore Molecular Medicine and Biopharma Opportunities in China

02 Mar 2007

China is increasingly becoming an attractive destination for biotechnology and pharmaceutical research, an international forum will be held at The Univeristy of Hong Kong to discuss the advances in molecular medicine in China, identify important market opportunities – from stell cell research to cardiovascular disease, and to explore biotechnology and biopharmaceutical opportunities in China.

The "MGH-HKU-Nature China Forum on Molecular Medicine and Biopharma Opportunities" is co-organized by Massachusetts General Hospital, Harvard Medical School (MGH), The University of Hong Kong (HKU) and Nature Publishing Group (Nature).

The two-day forum will be opened by Mr. Francis Ho, Permanent Secretary for Commerce, Industry and Technology (Communications and Technology), The Government of HKSAR in the presence of HKU Vice-Chancellor Professor Lap-Chee Tsui and over 200 leading academic and scientific scientists from around the globe, including Professor David Ho of Aaron Diamond AIDS Research Centre, The Rockfeller University, Professor Jerry Yang of Centre for Regenerative Biology, University of Connecticut and Professor Douglas Melton of Harvard Stem Cell Institute. For speakers and forum information please visit http://www.nature.com/nature/meetings/china.

Media representatives are cordially invited to cover the event. The details are:

Opening Ceremony and 2-day Forum

Venue: Lecture Theatre, Cheung Kung Hai Conference Centre, G/F, William MW Mong Block, Li Ka Shing Faculty of Medicine, HKU, Sasson Rd, HK.

Opening Ceremony: 5 March 2007 (Mon) 8.45am

Forum: 5 March 2007 (Mon) 9am to 5pm & 6 March 2006 (Tue) 9.30am to 6pm

Media Briefing on "Biotechnology and Biopharmaceutical Opportunities in China"

Date: 5 March 2007 (Mon)

Time: 10.30am

Venue: Conference Room, 6/F William MW Mong Block, Li Ka Shing Faculty of Medicine, HKU, 21 Sasson Road, HK.

Speakers and topics:

- "Interactions between Academic Research and Industry on Drug Discovery" by HKU Professor Vanhoutte,

- "building an Integrated Biomedical Research Institute for Innovative Medicine in China" by Dr. Ling Chen, Director General, Guanzhou Institute of Biomedicine and Health, Chinese Academy of Sciences,

- "financing China's Biotechnology Industry" by Mr. Gerald Chan, Chairman of Morningside Group

For media enquiries, please contact Mr. Terrence Poon, Li Ka Shing Faculty of Medicine HKU (Tel: 2819 9305).